Panbrain Lume Offers a Drug-Free Path to Deeper Sleep and Faster Sleep Onset in Just 8 Minutes, Now Live on Kickstarter
NEW HAVEN, Conn., Nov. 28, 2025 /PRNewswire/ -- In a bold fusion of cutting-edge neuroscience and ancient Eastern wellness principles, Dr. Nailin Yao, a former Yale postdoctoral fellow in psychiatry, today announces the launch of Panbrain Lume. This revolutionary intranasal near-infrared (NIR) photobiomodulation device is designed to combat the global sleep crisis with a simple, 8-minute nightly routine. Backed by robust science, Panbrain Lume is clinically engineered to speed up the onset of sleep and significantly increase deep sleep duration, now available on Kickstarter.
From the Ivy League to Your Nightstand: The Science of Light
The core technology leverages near-infrared light, a specific and beneficial spectrum that is the primary active component of sunlight. For centuries, Eastern practices like moxibustion (the burning of mugwort to warm acupuncture points) and Shai Bei (sunbathing to absorb the sun's "Yang Qi" or vital energy) have harnessed the power of warmth and light to restore vitality and balance in the body.
Modern science now validates this ancient intuition. The mechanism is rooted in our cells' powerplants: the mitochondria.
"Think of Lume as targeted, digital sunshine for your brain," explains Dr. Yao. "Just as the ancient practice of 'Shai Bei' uses sunlight to boost 'Yang Qi' and invigorate the body, the near-infrared light from Lume directly energizes the mitochondria in your brain cells. This enhances cellular energy production (ATP), reduces inflammation, and promotes the brain's natural healing and repair processes – which is precisely what happens during deep, restorative sleep."
The 8-Minute Secret to Deeper Sleep
The innovation of Lume lies in its delivery system. The delicate tissues inside the nasal cavity are rich with blood vessels and provide direct access to the brain's key sleep-regulating centers. By delivering a gentle, targeted stream of near-infrared light through this pathway at bedtime, Lume effectively "tells" the brain to wind down and prepare for a night of profound recovery.
- Fall Asleep Faster: Calms the nervous system to quiet the mind and accelerate the transition to sleep.
- Unlock More Deep Sleep: Enhances the brain's natural ability to enter and sustain the critical deep sleep (slow-wave sleep) phase, which is essential for memory consolidation, physical recovery, and hormonal regulation.
- Wake Up Reborn: Users report waking up feeling genuinely refreshed, mentally clear, and energized for the day ahead.
A Trusted Solution for a Sleepless World
In a market saturated with unproven gadgets and supplements, Lume stands apart. Its foundation in peer-reviewed photobiomodulation research, combined with the impeccable credentials of its founder, offers a level of credibility that is rare.
"We are not selling magic; we are selling accessible, proven science," Dr. Yao states. "For too long, the West has viewed Eastern concepts like 'Qi' as mystical. Now, we can measure their effects. Enhancing mitochondrial function is the measurable, scientific equivalent of 'boosting your Yang energy.' This is the future of wellness: a synergy of the best from both worlds to solve fundamental human problems."
Secure Your Pledge, Reclaim Your Sleep
Lume is now available for a limited time on Kickstarter with special early-bird pricing starting at $330. This is an opportunity to be among the first to experience this revolutionary approach to sleep enhancement, backed by a 30-day money-back guarantee.
To support the campaign and pre-order your Lume device, visit the Kickstarter page here: https://www.kickstarter.com/projects/panbraincares/panbrain-lume?ref=f52yyq
About Dr. Nailin Yao and PanbrainTechnologies
Dr. Nailin Yao is a former postdoctoral fellow in Psychiatry at Yale University School of Medicine and a recognized expert in the intersection of neuroscience and technology. Her company, Panbrain Technologies, is dedicated to developing elegant, science-backed consumer health devices that leverage brain-machine interface principles for everyday wellness.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Yale-Trained Neuroscientist Unveils "Digital Sunshine" Device, Merging Ancient Eastern Wisdom with Modern Brain Science to Revolutionize Sleep
SHANGHAI, April 2, 2026 /PRNewswire/ -- The 12th Annual China Healthcare Investment Conference (CHIC 2026) capped the first day of its two-day program with a celebratory Awards Gala Dinner held at The Ritz-Carlton Hotel Pudong, Shanghai. The evening, co-hosted by Founding Platinum Sponsor Wilson Sonsini and the BayHelix Group, recognized outstanding achievements in healthcare investment, financing, and deal-making over the past year.
This year's awards honored the companies and individuals at the forefront of China's dynamic healthcare sector — from landmark licensing and partnership agreements to capital markets milestones and private financings that are reshaping the industry. Award recipients were selected through a formal vote conducted by CHIC's Founders and 2026 Organizing Committee & Working Group, whose collective expertise spans venture capital, private equity, and global healthcare leadership.
Award Winners
IPO of the Year
Winner: Insilico Medicine
Accepted by: Leah Liu, VP and Global Head of IR & Capital Markets, Insilico Medicine
Presenter: Richard Wang, China Partner, Wilson Sonsini
Private Financing of the Year — Tied
Co-Winner: Kailera Therapeutics
Accepted by: Shelley Liu, Head of China Business Development & Strategy, Hengrui (Kailera Therapeutics was built on Hengrui assets)
Presenter: Kan Chen, Co-Head of Healthcare, Qiming Venture Partners
Co-Winner: Vor Bio
Accepted by: Jianmin Fang, CEO, RemeGen (Vor Bio's leading project is from RemeGen)
Presenter: Cyber Cao, Managing Director, HSG
Deal of the Year — Tied
Co-Winner: Hengrui Pharma – GSK
Accepted by: Shelley Liu, Head of China Business Development & Strategy, Hengrui; and Ming Fang, PhD, Senior Director, Search & Evaluation, Business Development, GSK
Presenter: Steve Yang, Co-Founder, the BayHelix Group; Co-CEO, WuXi Apptec
Co-Winner: Innovent – Takeda
Accepted by: Sophy Wang, Board Secretary & Global BD, Innovent; and Eric Yeung, Head of Oncology and Global Business Development, Takeda
Presenter: Kevin Yuan, CEO, Hankang Capital
About CHIC 2026
The China Healthcare Investment Conference (CHIC) is a premier platform connecting innovation and investment in China's healthcare sector. Now in its 12th year, CHIC brings together senior decision-makers including venture capital and private equity investors, pharmaceutical executives, and biotech and medtech CEOs. The 2026 conference was held on March 23–24 at The Ritz-Carlton Hotel Pudong, Shanghai, under the theme "Innovation in Healthcare – The Answer to Uncertainty."
About the Gala Dinner Co-Hosts
Wilson Sonsini is a leading legal advisor to life sciences, and biotechnology industries, offering integrated counsel across the full spectrum of a company's life cycle — from early-stage intellectual property strategy and patent prosecution to complex technology transactions, licensing, collaborations, as well as M&As, IPOs and capital market offerings. As Founding Platinum Sponsor of CHIC, Wilson Sonsini has been a steadfast partner in the conference's mission to connect healthcare innovation with global capital.
The BayHelix Group is a non-profit professional organization of business leaders with a mission to shape the growth of the life sciences and healthcare industry. Founded in 2001 in the San Francisco Bay Area, BayHelix has grown to over 800 members globally with a strong presence in China and the US. BayHelix serves as a co-host of the CHIC Gala Dinner and is a longstanding partner in advancing the global development of China's healthcare sector.
CHIC 2026 Founding Individuals & Organizing Committee / Working Group
The following individuals served as the voting body for the CHIC 2026 Awards, representing the CHIC Founding Individuals and the Organizing Committee & Working Group.
Founders
Marietta Wu, Managing Director, Quan Capital
Frank Kung, Managing Partner, Vivo Capital
Hongbo Lu, Managing Member, NEXTBio Capital
James Li, Venture Partner, Frazier Lifesciences
Norman Chen, CEO, The Asian American Foundation
2026 Organizing Committee & Working Group
Cyber Cao, Managing Director, HSG
Jialing Dai, President & Publisher, PharmaDJ
Tess Cameron, Managing Director, RA Capital Management
Kan Chen, Co-Head of Healthcare, Qiming Venture Partners
Sean Zhang, Executive Director, Vivo Capital
Dandan Dong, Venture Partner, TCGX
Anna Chen, Partner, Frazier Life Sciences
Yuan Yuan, Head of Platform Development, China, NEXTBio Capita
Zhanghang Yan, Vice President, Quan Capital
Yun Gao, Principal, Lilly Asia Ventures
** This press release is distributed by PR Newswire through automated distribution system, for which the client assumes full responsibility. **
CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala
CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala
CHIC 2026 Honors Landmark Deals and Financings at Annual Awards Gala
